Breast Biopsy is removal of cells or tissues from doubtful areas of
breast. These cells or tissues are studied under a microscope to
verify the presence of cancer. When a hollow needle is used to remove
tissue samples from breast, it is known as core needle biopsy. It is
the typical way to rule out or diagnose breast cancer. Core needle
biopsy is done for the palpable mass or lump that can be felt, or
suspicious area which is seen after mammogram or imaging test. Fine
needle biopsy, also known as fine needle aspiration, removes the
cells from suspicious lump in breast. The needle used for fine needle
biopsy is thinner than the needle used for core needle biopsy.
According to the American Cancer Society, 252,710 new cases of
invasive breast cancer are projected to be diagnosed in women in the
U.S. in 2017. About 63,410 new cases of carcinoma in situ (CIS) are
anticipated to be diagnosed (CIS is non-invasive and is the earliest
form of breast cancer). About 40,610 women are expected to die from
breast cancer.
Request Report Brochure @
https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=35909
Different types of biopsies are core needle biopsy, fine needle
aspiration biopsy, vacuum-assisted biopsy, image-guided biopsy,
incisional biopsy, excisional biopsy, shave biopsy, punch biopsy,
endoscopic biopsy, and bone marrow aspiration & biopsy. Two major
types of biopsies are needle biopsy and surgical biopsy. Needle
biopsy involves usage of a needle to remove tissue sample. Surgical
biopsy involves an incision to collect tissue sample. Core needle
biopsy is done in imaging centers or hospitals. It is an image guided
biopsy procedure. Advantages of core needle biopsy and fine needle
biopsy are least chance of bruising or infection. If the lump is
confirmed benign, then surgical biopsy is not required. However,
there is a chance that the needle may miss the tumor cells, and hence
misinterpret it as non-cancerous cell. Fine needle aspiration has
false negative rate of 2% to 4%. Hence, fine needle aspiration can be
followed by core needle biopsy or surgical biopsy.
Based on utility, the global needle aspiration biopsy market can be
categorized into disposable and reusable. In terms of application,
the market can be segmented into tumor, inflammation, infection, and
others. Based on end-user, the global needle aspiration biopsy market
can be classified into diagnostic & imaging centers, hospitals,
academics & research centers, and others. Increase in prevalence
and incidence of cancer globally and rise in awareness about diseases
are the major factors fueling the growth of the global needle
aspiration biopsy market. However, technological advancements in
imaging such as computed tomography and magnetic resonance imaging
are likely to restrain the global needle aspiration biopsy market.
Emergence of fluid biopsy can also hamper the growth of the market.
Enquiry for discount on this report @
https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=35909
The global needle aspiration biopsy market can be segmented into five
major regions: North America, Europe, Asia Pacific, Latin America,
and Middle East & Africa. Asia Pacific is projected to reflect a
high CAGR due to significant patient population. Growing awareness
among patients as well as health care professionals has led to
increase in number of diagnosed cases of cancer in Asia, especially
in China and India. North America is projected to dominate the global
needle aspiration biopsy market due to factors such as rise in number
of reported cancer cases, high per capita health expenditure, and
significant investment in R&D for effective treatment
alternatives.
Key players in the global needle aspiration biopsy market include
Cook Medical, Boston Scientific Corporation, Hologic, Inc., Medax Srl
Unipersonale, Cardinal Health, Inc., C. R. Bard, Inc., Becton,
Dickinson and Company, Leica Biosystems Nussloch GmbH, Möller
Medical GmbH, Hakko Co. Ltd., Argon Medical Devices, Inc., and
COMPASS International Innovations, Inc.
About Us
Transparency Market Research is a next-generation market intelligence
provider, offering fact-based solutions to business leaders,
consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow,
evolve, and mature. Our real-time data collection methods along with
ability to track more than one million high growth niche products are
aligned with your aims. The detailed and proprietary statistical
models used by our analysts offer insights for making right decision
in the shortest span of time. For organizations that require specific
but comprehensive information we offer customized solutions through
adhoc reports. These requests are delivered with the perfect
combination of right sense of fact-oriented problem solving
methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems
with right methodology of research is the key to help enterprises
reach right decision.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email:
sales@transparencymarketresearch.com
Website:
https://www.transparencymarketresearch.com
No comments:
Post a Comment